Zazove Associates »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Zazove Associates

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Zazove Associates from 13F filings

Historical chart of Zazove Associates investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Zazove Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Zazove Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 23M 0.99
2023-09-30 $19M 21M 0.93

More positions owned by Zazove Associates

Ssr Mining In Note 2.500% 4/0 (Principal)
Southwest Airls Note 1.250% 5/0 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)
Nrg Energy DBCV 2.750% 6/0 (Principal)
Ares Capital Corp Note 4.625% 3/0 (Principal)
Middleby Corp Note 1.000% 9/0 (Principal)
Parsons Corp Del Note 0.250% 8/1 (Principal)
John Bean Technologies Corp Note 0.250% 5/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Tyler Tex Indpt Sch Dist Note 0.250% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Braemar Hotels & Resorts Note 4.500% 6/0 (Principal)

View all positions for Zazove Associates

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Calamos Advisors
Steelhead Partners
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1